Fabrice Chouraqui
Vermögen: 162 673 $ am 30.09.2026
Vermögen: 162 673 $ am 30.09.2026
Dr. Fabrice Chouraqui is an Independent Member-Governors Board at Orano Med Manufacturing SAS. He is on the Board of Directors at Orano Med Manufacturing SAS. Dr. Chouraqui was previously employed as a Chief Executive Officer & Executive Director by Pharming Group NV, a President by Novartis Pharmaceuticals Corp., and a Chief Executive Officer & Director by Cellarity Inc. He received his graduate degree from Universite Paris Cite, an MBA from INSEAD and a doctorate degree from Universite Paris Cite.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PHARMING GROUP NV 0.02% | 31.03.2026 | 161’425 ( 0.02% ) | 162 673 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| PHARMING GROUP N.V. | Vorstandsvorsitzender | 29.09.2026 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Präsident | 01.01.2019 |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Vorstandsvorsitzender | 12.05.2025 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen